Stay updated on Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Core study details such as interventions, eligibility criteria, primary outcome measures, enrollment, and locations appear unchanged between the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T21:11:52.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    2%
    Check dated 2025-10-06T08:58:24.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T07:32:52.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No other substantive changes to core content, pricing, stock, or proper nouns.
    Difference
    0.1%
    Check dated 2025-09-14T23:10:38.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T19:47:00.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as various types of antibodies and proteins, while removing numerous disease-related attributes and classifications.
    Difference
    2%
    Check dated 2025-08-31T12:33:37.000Z thumbnail image

Stay in the know with updates to Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.